Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Topiramate Tablet, Film Coated
Product Images NDC 70518-4515
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-4515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This is a comparison of cumulative rates for time to first seizure between two groups receiving different doses of topiramate. The study involves 234 participants taking 50 mg/day and 236 participants taking 400 mg/day. The p-value for the comparison is 0.00002, indicating a significant difference between the two groups. The graph shows the time in days on the x-axis and the cumulative rates for seizures on the y-axis.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Remedy_label (Remedy Label)
This is a description of Topiramate Tablet, with a strength of 25 mg and a quantity of 120 tablets. It is a round yellow tablet that should be protected from moisture and stored between 20-25°C. The tablet is repackaged by RemedyRepack Inc. and has an NDC number 70518-4516-00. The manufacturer is Unichem located in Ghaziabad, India. It is important to keep this medication out of the reach of children. Additional dosage information can be found in the insert included with the packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
